Effects of 5-FU and heparin-based portal infusion chemotherapy combined with MMC and CDDP after curative resection of pancreatic cancer.

Effects of 5-FU and heparin-based portal infusion chemotherapy combined with MMC and CDDP after curative resection of pancreatic cancer. - 5-FU and heparin-based portal infusion chemotherapy after the resection of pancreatic cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002976

Enrollment

Registered

2010-01-20

Start date

2001-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients after the resection of pancreatic cancer

Interventions

with the portal infusion chemotherapy after the resection of pancreatic cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases with the curative resection of pancreatic cancer

Exclusion criteria

Exclusion criteria: inoperable cases

Design outcomes

Primary

Measure	Time frame
overall survival	—

Countries

Japan

Contacts

Public ContactMinoru Kitago

Department of Surgery, Keio University School of Medicine Department of Surgery

contact@keio-hpbts.jp03-3353-1211(ext62529)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026